Showing results (1421-1430 of 1,520) with videos related to
Sort By:
Pageof 152
Neuro-Oncology|April 28, 2023
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromasAndrea M Gross, Eva Dombi, Pamela L Wolters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancerSuparna Bonthala Wedam, Jennifer A Low, Sherry X Yang, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanomaSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.Journal of Nutrition Education and Behavior|February 13, 2017
A Multicomponent, School-Based Intervention, the Shaping Healthy Choices Program, Improves Nutrition-Related OutcomesRachel E Scherr, Jessica D Linnell, Madan Dharmar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2020
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II StudyErika J Lampert, Alexandra Zimmer, Michelle Padget, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignanciesShivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.JAMA|November 22, 2001
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trialE P Orringer, J F Casella, K I Ataga, et al.Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II StudyAnish Thomas, Rasa Vilimas, Christopher Trindade, et al.Clinical & Experimental Metastasis|September 29, 2011
Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brainYongzhen Qian, Emily Hua, Kheem Bisht, et al.Pageof 152